American Diabetes Association--63rd Scientific Sessions. Preclinical data. 13-17 June 2003, New Orleans, LA, USA.
Evans
Liz
L
Thomson Current Drugs, Middlesex House, 34-42 Cleveland Street, London W1T 4JE, UK. liz.evans@current-drugs.com
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D018932:Chemokine CCL2 / Q000037:antagonists & inhibitors; D016373:DNA, Antisense / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy; D003929:Diabetic Neuropathies / Q000188:drug therapy; D018819:Dipeptidyl Peptidase 4 / Q000187:drug effects; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists; D013777:Tetrazoles / Q000627:therapeutic use; D014157:Transcription Factors / Q000819:agonists; D019010:Vascular Cell Adhesion Molecule-1 / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D018932:Chemokine CCL2; D016373:DNA, Antisense; D018696:Neuroprotective Agents; D011480:Protease Inhibitors; D018160:Receptors, Cytoplasmic and Nuclear; D013777:Tetrazoles; D014157:Transcription Factors; D019010:Vascular Cell Adhesion Molecule-1; D018819:Dipeptidyl Peptidase 4; C081643:candesartan